Image-based drug screening of ALL cells co-cultured with MSC demonstrated high cytotoxic specificity of PARP1/2 inhibitors for ALL relative to non-cancer BMSC samples, as determined by IC50 values for each sample (Fig. 4g, h). The gene discussed is PARP1; the disease is acute lymphoblastic leukemia.